These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 35279069)
21. PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal use of antibiotics in the emergency department (PRONTO): protocol for a multicentre, open-label, randomised controlled trial. Euden J; Thomas-Jones E; Aston S; Brookes-Howell L; Carman J; Carrol E; Gilbert S; Howard P; Hood K; Inada-Kim M; Llewelyn M; McGill F; Milosevic S; Niessen LW; Nsutebu E; Pallmann P; Schmidt P; Taylor-Robinson D; Welters I; Todd S; French N; BMJ Open; 2022 Jun; 12(6):e063424. PubMed ID: 35697438 [TBL] [Abstract][Full Text] [Related]
22. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial. Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B; PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346 [TBL] [Abstract][Full Text] [Related]
23. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Briel M; Schuetz P; Mueller B; Young J; Schild U; Nusbaumer C; Périat P; Bucher HC; Christ-Crain M Arch Intern Med; 2008 Oct; 168(18):2000-7; discussion 2007-8. PubMed ID: 18852401 [TBL] [Abstract][Full Text] [Related]
24. How to: implement procalcitonin testing in my practice. Neeser O; Branche A; Mueller B; Schuetz P Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016 [TBL] [Abstract][Full Text] [Related]
25. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Burkhardt O; Ewig S; Haagen U; Giersdorf S; Hartmann O; Wegscheider K; Hummers-Pradier E; Welte T Eur Respir J; 2010 Sep; 36(3):601-7. PubMed ID: 20185423 [TBL] [Abstract][Full Text] [Related]
26. Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials. Meier MA; Branche A; Neeser OL; Wirz Y; Haubitz S; Bouadma L; Wolff M; Luyt CE; Chastre J; Tubach F; Christ-Crain M; Corti C; Jensen JS; Deliberato RO; Kristoffersen KB; Damas P; Nobre V; Oliveira CF; Shehabi Y; Stolz D; Tamm M; Mueller B; Schuetz P Clin Infect Dis; 2019 Jul; 69(3):388-396. PubMed ID: 30358811 [TBL] [Abstract][Full Text] [Related]
27. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884 [TBL] [Abstract][Full Text] [Related]
28. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial. Keitel K; Kagoro F; Samaka J; Masimba J; Said Z; Temba H; Mlaganile T; Sangu W; Rambaud-Althaus C; Gervaix A; Genton B; D'Acremont V PLoS Med; 2017 Oct; 14(10):e1002411. PubMed ID: 29059253 [TBL] [Abstract][Full Text] [Related]
29. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Annane D; Reinhart K; Falsey AR; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Oliveira CF; Maravić-Stojković V; Verduri A; Beghé B; Cao B; Shehabi Y; Jensen JS; Corti C; van Oers JAH; Beishuizen A; Girbes ARJ; de Jong E; Briel M; Mueller B Lancet Infect Dis; 2018 Jan; 18(1):95-107. PubMed ID: 29037960 [TBL] [Abstract][Full Text] [Related]
30. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis. Ni W; Bao J; Yang D; Xi W; Wang K; Xu Y; Zhang R; Gao Z Infect Dis (Lond); 2019 Sep; 51(9):639-650. PubMed ID: 31355690 [No Abstract] [Full Text] [Related]
31. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD. Corti C; Fally M; Fabricius-Bjerre A; Mortensen K; Jensen BN; Andreassen HF; Porsbjerg C; Knudsen JD; Jensen JU Int J Chron Obstruct Pulmon Dis; 2016; 11():1381-9. PubMed ID: 27382274 [TBL] [Abstract][Full Text] [Related]
32. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia. Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357 [TBL] [Abstract][Full Text] [Related]
33. Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial. Tang J; Long W; Yan L; Zhang Y; Xie J; Lu G; Yang C BMC Infect Dis; 2013 Dec; 13():596. PubMed ID: 24341820 [TBL] [Abstract][Full Text] [Related]
34. Antibiotics duration guided by biomarkers in hospitalized adult patients; a systematic review and meta-analysis. Elnajdy D; El-Dahiyat F Infect Dis (Lond); 2022 Jun; 54(6):387-402. PubMed ID: 35175169 [TBL] [Abstract][Full Text] [Related]
35. C reactive protein-guided prescription of antibiotics for children under 12 years with respiratory symptoms in Kyrgyzstan: protocol for a randomised controlled clinical trial with 14 days follow-up. Isaeva E; Bloch J; Poulsen A; Kurtzhals J; Reventlow S; Siersma V; Akylbekov A; Sooronbaev T; Munck Aabenhus R; Kjærgaard J BMJ Open; 2023 Apr; 13(4):e066806. PubMed ID: 37041063 [TBL] [Abstract][Full Text] [Related]
36. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis. Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153 [TBL] [Abstract][Full Text] [Related]
37. Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection. Huang DT; Yealy DM; Filbin MR; Brown AM; Chang CH; Doi Y; Donnino MW; Fine J; Fine MJ; Fischer MA; Holst JM; Hou PC; Kellum JA; Khan F; Kurz MC; Lotfipour S; LoVecchio F; Peck-Palmer OM; Pike F; Prunty H; Sherwin RL; Southerland L; Terndrup T; Weissfeld LA; Yabes J; Angus DC; N Engl J Med; 2018 Jul; 379(3):236-249. PubMed ID: 29781385 [TBL] [Abstract][Full Text] [Related]
38. Converting habits of antibiotic use for respiratory tract infections in German primary care - study protocol of the cluster-randomized controlled CHANGE-3 trial. Wollny A; Altiner A; Brand T; Garbe K; Kamradt M; Kaufmann-Kolle P; Leyh M; Poß-Doering R; Szecsenyi J; Uhlmann L; Voss A; Weber D; Wensing M; Löffler C Trials; 2019 Feb; 20(1):103. PubMed ID: 30728043 [TBL] [Abstract][Full Text] [Related]
39. Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial. Kyriazopoulou E; Liaskou-Antoniou L; Adamis G; Panagaki A; Melachroinopoulos N; Drakou E; Marousis K; Chrysos G; Spyrou A; Alexiou N; Symbardi S; Alexiou Z; Lagou S; Kolonia V; Gkavogianni T; Kyprianou M; Anagnostopoulos I; Poulakou G; Lada M; Makina A; Roulia E; Koupetori M; Apostolopoulos V; Petrou D; Nitsotolis T; Antoniadou A; Giamarellos-Bourboulis EJ Am J Respir Crit Care Med; 2021 Jan; 203(2):202-210. PubMed ID: 32757963 [No Abstract] [Full Text] [Related]
40. Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections. Li H; Luo YF; Blackwell TS; Xie CM Antimicrob Agents Chemother; 2011 Dec; 55(12):5900-6. PubMed ID: 21947386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]